button bars forest bayes pooled summary circles
 
deaths (OS)

mML - L1 - BRAF mutant metastatic/adv melanoma (mML) mML - 1st line (L1) mML - L1 - BRAF mutant

versus placebo plus SoC
atezolizumab plus SoC vs. placebo plus SoC 1 0.85 [0.65; 1.12], 1 RCT, I2=0%
inconclusive result

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons